Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3020

Actual shortage: 234 (8%)
Anticipated shortage: 20 (1%)
Avoided shortage: 9 (0%)
Resolved: 2757 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

28 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ZAMINE 28 3.0MG 0.030MG TABLET Resolved 2017-03-11 2020-09-04 561
ZAMINE 28 3MG 0.03MG TABLET Resolved 2021-02-12 2021-03-10 133984
ZAMINE 28 0.03MG 3MG TABLET Resolved 2023-09-07 2023-09-28 203831
ZAMINE 28 0.03MG 3MG TABLET Resolved 2023-11-24 2023-12-22 211487
ZAMINE 28 0.03MG 3MG TABLET Resolved 2024-01-26 2024-03-08 217475
ZAMINE 21 3.0MG 0.030MG TABLET Resolved 2017-03-11 2020-09-04 558
ZAMINE 21 0.03MG 3MG TABLET Resolved 2023-06-16 2023-07-27 195081
ZAMINE 21 0.03MG 3MG TABLET Resolved 2023-11-17 2023-12-22 210668
ZAMINE 21 0.03MG 3MG TABLET Resolved 2024-02-02 2024-03-29 218391
APO-TRIMEBUTINE 100MG TABLET Resolved 2021-11-24 2021-12-24 149793
APO-TRIMEBUTINE 100MG TABLET Resolved 2023-02-03 2023-04-17 183589
APO-TRIMEBUTINE 100MG TABLET Resolved 2023-07-14 2023-08-14 198716
TRI-CIRA LO 21 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2018-01-18 2018-02-23 36429
TRI-CIRA LO 28 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2018-12-27 2019-01-23 70526
TRI-CIRA LO 28 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-03-05 2019-05-21 77902
TRI-CIRA LO 28 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-03-13 2019-05-21 78558
TRI-CIRA LO 21 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-04-10 2019-08-26 80931
TRI-CIRA LO 28 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-08-07 2019-08-26 91109
TRI-CIRA LO 28 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-11-13 2019-11-18 98575
TRI-CIRA LO 21 0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG TABLET Resolved 2022-02-22 2022-03-07 155371

Showing 1 to 20 of 3020

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-FAMOTIDINE TAB 40MG USP Discontinued 2018-09-07 2018-09-15 60480
APO-FAMOTIDINE TAB 20MG USP Discontinued 2018-09-07 2018-09-15 60477
APO-EXEMESTANE Discontinued 2019-06-12 2019-06-12 86552
APO-ESCITALOPRAM 20MG TABLET Discontinued 2018-09-07 2018-09-15 60471
APO-ESCITALOPRAM 10MG TABLET Discontinued 2018-09-07 2018-11-16 60474
APO-ENALAPRIL 5MG TABLET Discontinued 2018-09-07 2018-11-02 60468
APO-ENALAPRIL 20MG TABLET Discontinued 2018-09-07 2018-11-19 60465
APO-ENALAPRIL 10MG TABLET Discontinued 2018-09-07 2018-12-05 60462
APO-DOXY TABS 100MG 100MG TABLET Discontinued 2017-03-30 2018-02-05 4707
APO-DOXY CAP 100MG 100MG CAPSULE Discontinued 2018-09-07 2018-09-29 60459
APO-DONEPEZIL 10MG TABLET Discontinued 2018-09-07 2018-09-15 60443
APO-DONEPEZIL 10MG TABLET Discontinued 2018-09-07 2018-09-15 60447
APO-DONEPEZIL 5MG TABLET Discontinued 2018-09-07 2018-10-12 60450
APO-DONEPEZIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60453
APO-DOCUSATE SODIUM 100MG CAPSULE Discontinued 2018-02-23 2019-03-29 40733
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Discontinued 2018-09-07 2018-09-15 60438
APO-DIPYRIDAMOLE 75MG TABLET Discontinued 2019-12-20 2019-12-21 101880
APO-DIPYRIDAMOLE 50MG TABLET Discontinued 2019-12-20 2020-07-30 101891
APO-DIPYRIDAMOLE 25MG TABLET Discontinued 2019-12-20 2020-07-30 101888
APO-DILTIAZ TZ 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1064

Showing 201 to 220 of 356